当前位置: X-MOL 学术Lancet Oncol. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Gut microbiome and immunotherapy response
The Lancet Oncology ( IF 41.6 ) Pub Date : 2017-11-09 , DOI: 10.1016/s1470-2045(17)30841-0
Talha Khan Burki

A new study by Vancheswaran Gopalakrishnan (MD Anderson Cancer Center, Houston, TX, USA) and colleagues has found that the composition of the gut microbiome affects the way patients with advanced melanoma respond to anti-PD-1 immunotherapy.

中文翻译:

肠道微生物组和免疫治疗反应

Vancheswaran Gopalakrishnan(美国德克萨斯州休斯顿的MD安德森癌症中心)及其同事进行的一项新研究发现,肠道微生物组的组成会影响晚期黑色素瘤患者对抗PD-1免疫疗法的反应方式。
更新日期:2017-11-30
down
wechat
bug